While purchasing medicine - It is important that you let us know what other medicine you are using.
This is for preventing unwanted drug interactions.


Want to ask us a professional question ? Call us or Connect VIA Skype





Skype Me™! 
 



 
 
 
 

ACAMOL TSINUN & SHAPA'AT NIGHT
Home >> Search Drug By Letter >> Search Drug By Letter: A >> ACAMOL TSINUN & SHAPA'AT NIGHT
Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 ACAMOL TSINUN & SHAPA'AT NIGHT
 
Package(a):
CAPLETS: 14.
Dosage(a):
The recommended dose should not be exceeded.
Adults and children over 12 years: 1-2 caplets at bedtime. If fever continues for more than 3 days, or if fever is absent but the patient’s condition has not improved within 7 days, or if pain persists for 5 days the physician should be consulted.
Patients over 60 years of age should consult their physician before taking this medicine.
Prescribing Restrictions:  None

Package(b):
CAPLETS: 14 (in combination pack with 35 day caplets).
Dosage(b):
The recommended dose should not be exceeded.
Adults and children over 12 years: 1-2 caplets at bedtime. If fever continues for more than 3 days, or if fever is absent but the patient’s condition has not improved within 7 days, or if pain persists for 5 days the physician should be consulted.
Patients over 60 years of age should consult their physician before taking this medicine.
Prescribing Restrictions:  None


Indications:
For the relief of cold, cough and nasal congestion associated with fever and pain, for night care.
Contra-Indications:
Known hypersensitivity to any ingredient of the preparation. Lactation. Newborn and premature infants. Asthma or other lower respiratory tract conditions, narrow-angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction. Concomitant use with MAOI therapy or within 14 days of discontinuation of such therapy. Severe hypertension and severe coronary artery disease. Subjects in, or at risk of developing respiratory failure (due to dextromethorphan content, in common with other centrally acting antitussive agents).
Special Precautions:
See package insert (OTC).
Side Effects:
See package insert (OTC).